Urinalysis: a comprehensive review

Urinalysis: a comprehensive review

Jeff A. Simerville

A complete urinalysis includes physical, chemical, and microscopic examinations. Midstream clean collection is acceptable in most situations, but the specimen should be examined within two hours of collection. Cloudy urine often is a result of precipitated phosphate crystals in alkaline urine, but pyuria also can be the cause. A strong odor may be the result of a concentrated specimen rather than a urinary tract infection. Dipstick urinalysis is convenient, but false-positive and false-negative results can occur. Specific gravity provides a reliable assessment of the patient’s hydration status. Microhematuria has a range of causes, from benign to life threatening. Glomerular, renal, and urologic causes of microhematuria often can be differentiated by other elements of the urinalysis. Although transient proteinuria typically is a benign condition, persistent proteinuria requires further work-up. Uncomplicated urinary tract infections diagnosed by positive leukocyte esterase and nitrite tests can be treated without culture. (Am Fam Physician 2005;71:1153-62. Copyright[c] 2005 American Academy of Family Physicians.)

**********

Urinalysis is invaluable in the diagnosis of urologic conditions such as calculi, urinary tract infection (UTI), and malignancy. It also can alert the physician to the presence of systemic disease affecting the kidneys. Although urinalysis is not recommended as a routine screening tool except in women who may be pregnant, physicians should know how to interpret urinalysis results correctly. This article reviews the correct method for performing urinalysis and the differential diagnosis for several abnormal results.

Specimen Collection

A midstream clean-catch technique usually is adequate in men and women. Although prior cleansing of the external genitalia often is recommended in women, it has no proven benefit. In fact, a recent study (1) found that contamination rates were similar in specimens obtained with and without prior cleansing (32 versus 29 percent). Urine must be refrigerated if it cannot be examined promptly; delays of more than two hours between collection and examination often cause unreliable results. (2)

Physical Properties: Color and Odor

Foods, medications, metabolic products, and infection can cause abnormal urine colors (Table 1). (3) Cloudy urine often is a result of precipitated phosphate crystals in alkaline urine, but pyuria also can be the cause.

[TABLE 1 OMITTED]

The normal odor of urine is described as urinoid; this odor can be strong in concentrated specimens but does not imply infection. Diabetic ketoacidosis can cause urine to have a fruity or sweet odor, and alkaline fermentation can cause an ammoniacal odor after prolonged bladder retention. Persons with UTIs often have urine with a pungent odor. Other causes of abnormal odors include gastrointestinal-bladder fistulas (associated with a fecal smell), cystine decomposition (associated with a sulfuric smell), and medications and diet (e.g., asparagus).

Dipstick Urinalysis

False-positive and false-negative results are not unusual in dipstick urinalysis (Table 2). The accuracy of this test in detecting microscopic hematuria, significant proteinuria, and UTI is summarized in Table 13. (4-13)

SPECIFIC GRAVITY

Urinary specific gravity (USG) correlates with urine osmolality and gives important insight into the patient’s hydration status. It also reflects the concentrating ability of the kidneys. Normal USG can range from 1.003 to 1.030; a value of less than 1.010 indicates relative hydration, and a value greater than 1.020 indicates relative dehydration. (14) Increased USG is associated with glycosuria and the syndrome of inappropriate antidiuretic hormone; decreased USG is associated with diuretic use, diabetes insipidus, adrenal insufficiency, aldosteronism, and impaired renal function. (14) In patients with intrinsic renal insufficiency, USG is fixed at 1.010–the specific gravity of the glomerular filtrate.

URINARY PH

Urinary pH can range from 4.5 to 8 but normally is slightly acidic (i.e., 5.5 to 6.5) because of metabolic activity. Ingestion of proteins and acidic fruits (e.g., cranberries) can cause acidic urine, and diets high in citrate can cause alkaline urine. (15-17) Urinary pH generally reflects the serum pH, except in patients with renal tubular acidosis (RTA). The inability to acidify urine to a pH of less than 5.5 despite an overnight fast and administration of an acid load is the hallmark of RTA. In type I (distal) RTA, the serum is acidic but the urine is alkaline, secondary to an inability to secrete protons into the urine. Type II (proximal) RTA is characterized by an inability to reabsorb bicarbonate. This situation initially results in alkaline urine, but as the filtered load of bicarbonate decreases, the urine becomes more acidic.

Determination of urinary pH is useful in the diagnosis and management of UTIs and calculi. Alkaline urine in a patient with a UTI suggests the presence of a urea-splitting organism, which may be associated with magnesium-ammonium phosphate crystals and can form staghorn calculi. Uric acid calculi are associated with acidic urine.

HEMATURIA

According to the American Urological Association, the presence of three or more red blood cells (RBCs) per high-powered field (HPF) in two of three urine samples is the generally accepted definition of hematuria.18-20 The dipstick test for blood detects the peroxidase activity of erythrocytes. However, myoglobin and hemoglobin also will catalyze this reaction, so a positive test result may indicate hematuria, myoglobinuria, or hemoglobin-uria. Visualization of intact erythrocytes on microscopic examination of the urinary sediment can distinguish hematuria from other conditions. Microscopic examination also may detect RBC casts or dysmorphic RBCs. Hematuria is divided into glomerular, renal (i.e., nonglomerular), and urologic etiologies (Table 4). (21)

[TABLE 4 OMITTED]

Glomerular Hematuria. Glomerular hematuria typically is associated with significant proteinuria, erythrocyte casts, and dysmorphic RBCs. However, 20 percent of patients with biopsy-proven glomerulonephritis present with hematuria alone. (22) IgA nephropathy (i.e., Berger’s disease) is the most common cause of glomerular hematuria.

Renal (Nonglomerular) Hematuria. Nonglomerular hematuria is secondary to tubulointerstitial, renovascular, or metabolic disorders. Like glomerular hematuria, it often is associated with significant proteinuria; however, there are no associated dysmorphic RBCs or erythrocyte casts. Further evaluation of patients with glomerular and nonglomerular hematuria should include determination of renal function and 24-hour urinary protein or spot urinary protein-creatinine ratio.

Urologic Hematuria. Urologic causes of hematuria include tumors, calculi, and infections. Urologic hematuria is distinguished from other etiologies by the absence of proteinuria, dysmorphic RBCs, and erythrocyte casts. Even significant hematuria will not elevate the protein concentration to the 2+ to 3+ range on the dipstick test. (23) Up to 20 percent of patients with gross hematuria have urinary tract malignancy; a full work-up with cystoscopy and upper-tract imaging is indicated in patients with this condition. (24) In patients with asymptomatic microscopic hematuria (without proteinuria or pyuria), 5 to 22 percent have serious urologic disease, and 0.5 to 5 percent have a genitourinary malignancy. (25-29)

Exercise-induced hematuria is a relatively common, benign condition that often is associated with long-distance running. Results of repeat urinalysis after 48 to 72 hours should be negative in patients with this condition. (30)

PROTEINURIA

In healthy persons, the glomerular capillary wall is permeable only to substances with a molecular weight of less than 20,000 Daltons. Once filtered, low-molecular-weight proteins are reabsorbed and metabolized by the proximal tubule cells. Normal urinary proteins include albumin, serum globulins, and proteins secreted by the nephron. Proteinuria is defined as urinary protein excretion of more than 150 mg per day (10 to 20 mg per dL) and is the hallmark of renal disease. Microal-buminuria is defined as the excretion of 30 to 150 mg of protein per day and is a sign of early renal disease, particularly in diabetic patients.

The reagent on most dipstick tests is sensitive to albumin but may not detect low concentrations of [gamma]-globulins and Bence Jones proteins. Dipstick tests for trace amounts of protein yield positive results at concentrations of 5 to 10 mg per dL–lower than the threshold for clinically significant proteinuria. (15) A result of 1+ corresponds to approximately 30 mg of protein per dL and is considered positive; 2+ corresponds to 100 mg per dL, 3+ to 300 mg per dL, and 4+ to 1,000 mg per dL. (31, 32) Dipstick urinalysis reliably can predict albuminuria with sensitivities and specificities of greater than 99 percent. (4) Asymptomatic proteinuria is associated with significant renal disease in less than 1.5 percent of patients. (4, 33)

Proteinuria can be classified as transient or persistent (Table 5). (21) In transient proteinuria, a temporary change in glomerular hemodynamics causes the protein excess; these conditions follow a benign, self-limited course.34,35 Orthostatic (postural) proteinuria is a benign condition that can result from prolonged standing; it is confirmed by obtaining a negative urinalysis result after eight hours of recumbency.

Persistent proteinuria is divided into three general categories: glomerular, tubular, and overflow. In glomerular proteinuria, the most common type, albumin is the primary urinary protein. Tubular proteinuria results when malfunctioning tubule cells no longer metabolize or reabsorb normally filtered protein. In this condition, low-molecular-weight proteins predominate over albumin and rarely exceed 2 g per day. In overflow proteinuria, low-molecular-weight proteins overwhelm the ability of the tubules to reabsorb filtered proteins.

Further evaluation of persistent proteinuria usually includes determination of 24-hour urinary protein excretion or spot urinary protein-creatinine ratio, microscopic examination of the urinary sediment, urinary protein electrophoresis, and assessment of renal function. (32)

GLYCOSURIA

Glucose normally is filtered by the glomerulus, but it is almost completely reabsorbed in the proximal tubule. Glycosuria occurs when the filtered load of glucose exceeds the ability of the tubule to reabsorb it (i.e., 180 to 200 mg per dL). Etiologies include diabetes mellitus, Cushing’s syndrome, liver and pancreatic disease, and Fanconi’s syndrome.

KETONURIA

Ketones, products of body fat metabolism, normally are not found in urine. Dipstick reagents detect acetic acid through a reaction with sodium nitroprusside or nitro-ferricyanide and glycine. Ketonuria most commonly is associated with uncontrolled diabetes, but it also can occur during pregnancy, carbohydrate-free diets, and starvation.

NITRITES

Nitrites normally are not found in urine but result when bacteria reduce urinary nitrates to nitrites. Many gram- negative and some gram-positive organisms are capable of this conversion, and a positive dipstick nitrite test indicates that these organisms are present in significant numbers (i.e., more than 10,000 per mL).

This test is specific but not highly sensitive. Thus, a positive result is helpful, but a negative result does not rule out UTI. (6) The nitrite dipstick reagent is sensitive to air exposure, so containers should be closed immediately after removing a strip. After one week of exposure, one third of strips give false-positive results, and after two weeks, three fourths give false-positive results. (36) Non-nitrate-reducing organisms also may cause false- negative results, and patients who consume a low-nitrate diet may have false-negative results.

LEUKOCYTE ESTERASE

Leukocyte esterase is produced by neutrophils and may signal pyuria associated with UTI. To detect significant pyuria accurately, five minutes should be allowed for the dipstick reagent strip to change color. Leukocyte casts in the urinary sediment can help localize the area of inflammation to the kidney.

Organisms such as Chlamydia and Ureaplasma urea-lyticum should be considered in patients with pyuria and negative cultures. Other causes of sterile pyuria include balanitis, urethritis, tuberculosis, bladder tumors, viral infections, nephrolithiasis, foreign bodies, exercise, glo-merulonephritis, and corticosteroid and cyclophospha-mide (Cytoxan) use.

BILIRUBIN AND UROBILINOGEN

Urine normally does not contain detectable amounts of bilirubin. Unconjugated bilirubin is water insoluble and cannot pass through the glomerulus; conjugated bili-rubin is water soluble and indicates further evaluation for liver dysfunction and biliary obstruction when it is detected in the urine.

Normal urine contains only small amounts of urobi-linogen, the end product of conjugated bilirubin after it has passed through the bile ducts and been metabolized in the intestine. Urobilinogen is reabsorbed into the por-tal circulation, and a small amount eventually is filtered by the glomerulus. Hemolysis and hepatocellular disease can elevate urobilinogen levels, and antibiotic use and bile duct obstruction can decrease urobilinogen levels.

Microscopic Urinalysis

Microscopic examination is an indispensable part of urinalysis; the identification of casts, cells, crystals, and bacteria aids in the diagnosis of a variety of conditions. To prepare a urine specimen for microscopic analysis, a fresh sample of 10 to 15 mL of urine should be centrifuged at 1,500 to 3,000 rpm for five minutes. The super-natant then is decanted and the sediment resuspended in the remaining liquid. (37) A single drop is transferred to a clean glass slide, and a cover slip is applied.

CELLS

Leukocytes may be seen under low- and high-power magnification (Figure 1). Men normally have fewer than two white blood cells (WBCs) per HPF; women normally have fewer than five WBCs per HPF.

[FIGURE 1 OMITTED]

Epithelial cells often are present in the urinary sediment. Squamous epithelial cells are large and irregularly shaped, with a small nucleus and fine granular cytoplasm; their presence suggests contamination. The presence of transitional epithelial cells is normal. These cells are smaller and rounder than squamous cells, and they have larger nuclei. The presence of renal tubule cells indicates significant renal pathology (Figure 2). Erythrocytes are best visualized under high-power magnification. Dysmorphic erythrocytes, which have odd shapes because of their passage through an abnormal glomerulus, suggest glomerular disease.

[FIGURE 2 OMITTED]

CASTS

Casts in the urinary sediment may be used to localize disease to a specific location in the genitourinary tract (Table 6). (38) Casts, which are a coagulum of Tamm-Horsfall mucoprotein and the trapped contents of tubule lumen, originate from the distal convoluted tubule or collecting duct during periods of urinary concentration or stasis, or when urinary pH is very low. Their cylindrical shape reflects the tubule in which they were formed and is retained when the casts are washed away. The pre-dominant cellular elements determine the type of cast: hyaline, erythrocyte, leukocyte, epithelial, granular, waxy, fatty, or broad (Figure 3).

[FIGURE 3 OMITTED]

CRYSTALS

Crystals may be seen in the urinary sediment of healthy patients (Figure 4). Calcium oxalate crystals have a refractile square “envelope” shape that can vary in size.

[FIGURE 4 OMITTED]

Uric acid crystals are yellow to orange-brown and may be diamond- or barrel-shaped. Triple phosphate crystals may be normal but often are associated with alkaline urine and UTI (typically associated with Proteus spe-cies). These crystals are colorless and have a characteristic “coffin lid” appearance. Cystine crystals are colorless, have a hexagonal shape, and are present in acidic urine, which is diagnostic of cystinuria.

BACTERIURIA

Gram-negative streptococci and staphylococci can be distinguished by their characteristic appearance under high-powered magnification.

Gram staining can help guide antibiotic therapy, but it is not indicated in routine outpatient practice. Clean-catch specimens from female patients frequently are contaminated by vaginal flora. In these patients, five bacteria per HPF represents roughly 100,000 colony-forming units (CFU) per mL, the classic diagnostic criterion for asymptomatic bacteriuria and certainly compatible with a UTI. In symptomatic patients, a colony count as low as 100 CFU per mL suggests UTI, and antibiotics should be considered. The presence of bacteria in a properly collected male urine specimen is suggestive of infection, and a culture should be obtained.

Strength of Recommendations

Key clinical recommendation Label References

Patients with dipstick results of 3+ or greater B 5

may have significant proteinuria; further

work-up is indicated.

Patients with microscopic hematuria (i.e., at C 19, 20

least three red blood cells per high-power

field in two of three specimens) should be

evaluated to exclude renal and urinary tract

disease.

Exercise-induced hematuria is a relatively C 30

common, self-limited, and benign condition.

Because results of repeat urinalysis after 48

to 72 hours should be negative in patients with

this condition, extended testing is not

warranted.

A = consistent, good-quality patient-oriented evidence,

B = inconsistent or limited-quality patient-oriented evidence,

C = consensus, disease-oriented evidence, usual practice, opinion, or

case series. See page 1046 for more information.

TABLE 2

Causes of False-Positive and False-Negative Urinalysis Results

Dipstick test False positive False negative

Bilirubin Phenazopyridine Chlorpromazine

(Pyridium) (Thorazine), selenium

Blood Dehydration, exercise, Captopril (Capoten),

hemoglobinuria, elevated specific

menstrual blood, gravity, pH < 5.1,

myoglobinuria proteinuria,

vitamin C

Glucose Ketones, levodopa Elevated specific

(Larodopa) gravity, uric acid,

vitamin C

Ketones Acidic urine, elevated Delay in examination of

specific gravity, urine

mesna (Mesnex),

phenolphthalein, some

drug metabolites

(e.g., levodopa)

Leukocyte Contamination Elevated specific

esterase gravity, glycosuria,

ketonuria,

proteinuria, some

oxidizing drugs

(cephalexin [Keflex],

nitrofurantoin

[Furadantin],

tetracycline,

gentamicin),

vitamin C

Nitrites Contamination, exposure Elevated specific

of dipstick to air, gravity, elevated

phenazopyridine urobilinogen levels,

nitrate reductase-

negative bacteria, pH

< 6.0, vitamin C

Protein Alkaline or Acidic or dilute urine,

concentrated urine, primary protein is

phenazopyridine, not albumin

quaternary ammonia

compounds

Specific gravity * Dextran solutions, IV Alkaline urine

radiopaque dyes,

proteinuria

Urobilinogen Elevated nitrite —

levels,

phenazopyridine

IV = intravenous.

*–False-positive results are caused by false elevation,

false-negative results are caused by false depression.

TABLE 3

Accuracy of Urinalysis for Disease Detection

Condition Test Results Sensitivity (%)

Microscopic Dipstick [greater than 91 to 100

hematuria (4) or equal to]

1+ blood

Significant Dipstick [greater than 96

proteinuria (5) or equal to]

3+ protein

Culture-confirmed Dipstick Abnormal 72 to 97

UTI (6-13) leukocyte

esterase

Abnormal 19 to 48

nitrites

Abnormal 46 to 100

leukocyte

esterase or

nitrites

[greater than 63 to 83

or equal to]

3+ protein

[greater than 68 to 92

or equal to]

1+ blood

Any of the above 94 to 100

abnormalities

Microscopy > 5 WBCs per HPF 90 to 96

> 5 RBCs per HPF 18 to 44

Bacteria (any 46 to 58

amount)

Condition Test Results Specificity (%)

Microscopic Dipstick [greater than 65 to 99

hematuria (4) or equal to]

1+ blood

Significant Dipstick [greater than 87

proteinuria (5) or equal to]

3+ protein

Culture-confirmed Dipstick Abnormal 41 to 86

UTI (6-13) leukocyte

esterase

Abnormal 92 to 100

nitrites

Abnormal 42 to 98

leukocyte

esterase or

nitrites

[greater than 50 to 53

or equal to]

3+ protein

[greater than 42 to 46

or equal to]

1+ blood

Any of the above 14 to 26

abnormalities

Microscopy > 5 WBCs per HPF 47 to 50

> 5 RBCs per HPF 88 to 89

Bacteria (any 89 to 94

amount)

Condition Test Results PPV NPV

Microscopic Dipstick [greater than NA NA

hematuria (4) or equal to]

1+ blood

Significant Dipstick [greater than NA NA

proteinuria (5) or equal to]

3+ protein

Culture-confirmed Dipstick Abnormal 43 to 56 82 to 91

UTI (6-13) leukocyte

esterase

Abnormal 50 to 83 70 to 88

nitrites

Abnormal 52 to 68 78 to 98

leukocyte

esterase or

nitrites

[greater than 53 82

or equal to]

3+ protein

[greater than 51 88

or equal to]

1+ blood

Any of the above 44 100

abnormalities

Microscopy > 5 WBCs per HPF 56 to 59 83 to 95

> 5 RBCs per HPF 27 82

Bacteria (any 54 to 88 77 to 86

amount)

PPV = positive predictive value, NPV = negative predictive value,

NA = not applicable, UTI = urinary tract infection, WBCs = white

blood cells, HPF = high-powered field; RBCs = red blood cells.

Information from references 4 through 13.

TABLE 5

Common Causes of Proteinuria

Transient proteinuria Secondary glomerular Tubular causes

causes

Congestive heart Alport’s syndrome Aminoaciduria

failure Amyloidosis Drugs (e.g.,

Dehydration Collagen vascular NSAIDs,

Emotional stress diseases (e.g., antibiotics)

Exercise systemic lupus Fanconi syndrome

Fever erythematosus) Heavy metal

Orthostatic Diabetes mellitus ingestion

(postural) Drugs (e.g., Hypertensive

proteinuria NSAIDs, nephrosclerosis

Seizures penicillamine Interstitial

Persistent proteinuria [Cuprimine], nephritis

Primary glomerular gold, ACE Overflow causes

causes inhibitors) Hemoglobinuria

Focal segmental Fabry’s disease Multiple myeloma

glomerulone- Infections (e.g., Myoglobinuria

phritis HIV, syphilis,

IgA nephropathy hepatitis, post-

(i.e., Berger’s streptococcal

disease) infection)

IgM nephropathy Malignancies (e.g.,

Membranoprolifera- lymphoma, solid

tive glomerulo- tumors)

nephritis Sarcoidosis

Membranous Sickle cell disease

nephropathy

Minimal change

disease

NSAIDs = nonsteroidal anti-inflammatory drugs, ACE = angiotensin-

converting enzyme, HIV = human immunodeficiency virus.

Adapted with permission from Ahmed Z, Lee J. Asymptomatic urinary

abnormalities. Hematuria and proteinuria. Med Clin North Am

1997,81:650.

TABLE 6

Urinary Casts and Associated Pathologic

Conditions

Type of cast Composition Associated conditions

Hyaline Mucoproteins Pyelonephritis, chronic renal

disease

May be a normal finding

Erythrocyte Red blood Glomerulonephritis

cells May be a normal finding in

patients who play contact

sports

Leukocyte White blood Pyelonephritis,

cells glomerulonephritis,

interstitial nephritis, renal

inflammatory processes

Epithelial Renal tubule Acute tubular necrosis,

cells interstitial nephritis,

eclampsia, nephritic

syndrome, allograft

rejection, heavy metal

ingestion, renal disease

Granular Various cell Advanced renal disease

types

Waxy Various cell Advanced renal disease

types

Fatty Lipid-laden Nephrotic syndrome, renal

renal tubule disease, hypothyroidism

cells

Broad Various cell End-stage renal disease

types

Information from reference 38.

REFERENCES

(1.) Lifshitz E, Kramer L. Outpatient urine culture: does collection technique matter? Arch Intern Med 2000;160:2537-40.

(2.) Rabinovitch A. Urinalysis and collection, transportation, and preservation of urine specimens: approved guideline. 2d ed. Wayne, Pa.: National Committee for Clinical Laboratory Standards, 2001. NCCLS document GP16-A2.

(3.) Hanno PM, Wein AJ, Malkowicz SB. Clinical manual of urology. 3d ed. New York: McGraw-Hill, 2001.

(4.) Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA 1989;262:1214-9.

(5.) Agarwal R, Panesar A, Lewis RR. Dipstick proteinuria: can it guide hypertension management? Am J Kidney Dis 2002;39:1190-5.

(6.) Pels RJ, Bor DH, Woolhandler S, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. II. Bacteriuria. JAMA 1989;262:1221-4.

(7.) Sultana RV, Zalstein S, Cameron P, Campbell D. Dipstick urinalysis and the accuracy of the clinical diagnosis of urinary tract infection. J Emerg Med 2001;20:13-9.

(8.) Smith P, Morris A, Reller LB. Predicting urine culture results by dipstick testing and phase contrast microscopy. Pathology 2003;35:161-5.

(9.) Van Nostrand JD, Junkins AD, Bartholdi RK. Poor predictive ability of urinalysis and microscopic examination to detect urinary tract infection. Am J Clin Pathol 2000;113:709-13.

(10.) Eidelman Y, Raveh D, Yinnon AM, Ballin J, Rudensky B, Gottehrer NP. Reagent strip diagnosis of UTI in a high-risk population. Am J Emerg Med 2002;20:112-3.

(11.) Lammers RL, Gibson S, Kovacs D, Sears W, Strachan G. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med 2001;38:505-12.

(12.) Semeniuk H, Church D. Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol 1999;37:3051- 2.

(13.) Leman P. Validity of urinalysis and microscopy for detecting urinary tract infection in the emergency department. Eur J Emerg Med 2002;9:141-7.

(14.) Kavouras SA. Assessing hydration status. Curr Opin Clin Nutr Metab Care 2002;5:519-24.

(15.) Sheets C, Lyman JL. Urinalysis. Emerg Med Clin North Am 1986;4: 263-80.

(16.) Kiel DP, Moskowitz MA. The urinalysis: a critical appraisal. Med Clin North Am 1987;71:607-24.

(17.) Benejam R, Narayana AS. Urinalysis: the physician’s responsibility. Am Fam Physician 1985;31:103-11.

(18.) Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 1989;141:350-5.

(19.) Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part I: definition, detection, prevalence, and etiology. Urology 2001;57:599-603.

(20.) Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001;57:604-10.

(21.) Ahmed Z, Lee J. Asymptomatic urinary abnormalities. Hematuria and proteinuria. Med Clin North Am 1997;81:641-52.

(22.) Fassett RG, Horgan BA, Mathew TH. Detection of glomerular bleeding by phase-contrast microscopy. Lancet 1982;1:1432-4.

(23.) Brendler, CB. Evaluation of the urologic patient: history, physical exami-nation and urinalysis. In: Campbell MF, Walsh PC. Campbell’s Urology. 7th ed. Philadelphia: Saunders, 1998:144-56.

(24.) Sutton JM. Evaluation of hematuria in adults. JAMA 1990;263:2475-80.

(25.) Mohr DN, Offord KP, Owen RA, Melton LJ 3d. Asymptomatic micro-hematuria and urologic disease. A population-based study. JAMA 1986;256:224-9.

(26.) Khan MA, Shaw G, Paris AM. Is microscopic haematuria a urological emergency? BJU Int 2002;90:355-7.

(27.) Mohr DN, Offord KP, Melton LJ 3d. Isolated asymptomatic microhe-maturia: a cross-sectional analysis of test- positive and test-negative patients. J Gen Intern Med 1987;2:318-24.

(28.) Messing EM, Young TB, Hunt VB, Emoto SE, Wehbie JM. The sig-nificance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol 1987;137:919-22.

(29.) Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000;163:524-7.

(30.) Siegel AJ, Hennekens CH, Solomon HS, Van Boeckel B. Exercise-related hematuria. Findings in a group of marathon runners. JAMA 1979;241:391-2.

(31.) House AA, Cattran DC. Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care. CMAJ 2002;166: 348-53.

(32.) Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician 2000;62:1333-40.

(33.) Von Bonsdorff M, Koskenvuo K, Salmi HA, Pasternack A. Prevalence and causes of proteinuria in 20-year old Finnish men. Scand J Urol Nephrol 1981;15:285-90.

(34.) Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR. Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 1982;97:516-9.

(35.) Rytand DA, Spreiter S. Prognosis in postural (orthostatic) proteinuria: forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis. N Engl J Med 1981;305:618-21.

(36.) Gallagher EJ, Schwartz E, Weinstein RS. Performance characteristics of urine dipsticks stored in open containers. Am J Emerg Med 1990;8: 121-3.

(37.) Fogazzi GB, Garigali G. The clinical art and science of urine microscopy. Curr Opin Nephrol Hypertens 2003;12:625- 32.

(38.) Graham JC, Galloway A. ACP best practice no. 167: the laboratory diagnosis of urinary tract infection. J Clin Pathol 2001;54:911-9.

JEFF A. SIMERVILLE, M.D., WILLIAM C. MAXTED, M.D., and JOHN J. PAHIRA, M.D. Georgetown University School of Medicine, Washington, D.C.

JEFF A. SIMERVILLE, M.D., is a fifth-year resident in urology at Georgetown University Medical Center, Washington, D.C. He received his medical degree from Georgetown University School of Medicine.

WILLIAM C. MAXTED, M.D., is professor of urology at Georgetown University School of Medicine, where he received his medical degree and completed a residency in urology.

JOHN J. PAHIRA, M.D., is professor of urology at Georgetown University School of Medicine. He received his medical degree from Pennsylvania State University Milton S. Hershey Medical Center College of Medicine, Hershey, and a residency in urology at the Hospital of the University of Pennsylvania, Philadelphia. Address correspondence to Jeff A. Simerville, M.D., 6641 Wakefield Dr., #411, Alexandria, VA 22307 (e-mail: jsimerville@cox.net). Reprints are not available from the authors.

The authors indicate that they do not have any conflicts of interest. Sources of funding: none reported.

Figures 1 through 4 reprinted from the National Institutes of Health Clinical Center Department of Laboratory Medicine, Bethesda, Md.

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group